Effect of Remote Ischemic Preconditioning in the Elderly Patients With Coronary Artery Disease With Diabetes Mellitus Undergoing Elective Drug-Eluting Stent Implantation
Restricted accessResearch articleFirst published online September, 2014
Effect of Remote Ischemic Preconditioning in the Elderly Patients With Coronary Artery Disease With Diabetes Mellitus Undergoing Elective Drug-Eluting Stent Implantation
There is conflicting evidence regarding the effectiveness of remote ischemic preconditioning (RIPC) in patients undergoing elective percutaneous coronary intervention (PCI). Therefore, we prospectively enrolled elderly patients with coronary heart disease (CHD) with diabetes mellitus (DM) undergoing elective drug-eluting stent (DES) implantation. They were randomized to receive RIPC within 2 hours before PCI (n = 102) or not (controls, n = 98). Baseline clinical characteristics were similar between the 2 groups. Despite a trend toward decline, the median high-sensitivity cardiac troponin I (hscTnI) level (P = .256) and the incidence of myocardial infarction (MI) type 4a (P = .106) in the RIPC group 16 hours after PCI procedure was not significantly different from the control group. The RIPC could attenuate the release of a myocardial biomarker but failed to show a significant effect on hscTnI level or MI type 4a incidence after PCI procedure in elderly patients with CHD having DM undergoing elective DES implantation.
ThygesenKAlpertJSJaffeAS. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–1598.
2.
PortoISelvanayagamJBVan GaalWJ. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006;114(7):662–669.
3.
BahrmannPFigullaHRWagnerMFerrariMVossAWernerGS. Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions. Heart. 2005;91(9):1186–1192.
4.
DaviesWRBrownAJWatsonW. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circ Cardiovasc Interv. 2013;6(3):246–251.
5.
FeldmanDNKimLReneAGMinutelloRMBergmanGWongSC. Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 2011;77(7):1020–1030.
6.
HeuschGKleinbongardPBöseD. Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009;120(18):1822–1836.
7.
HeuschG. Cardioprotection: chances and challenges of its translation to the clinic. Lancet. 2013;381(9861):166–175.
8.
American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(suppl 1):S11–S66.
9.
MaYCZuoLChenJH. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944.
10.
MurryCEJenningsRBReimerKA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–1136.
TamareilleSMateusVGhabouraN. RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol. 2011;106(6):1329–1339.
13.
HeuschGMusiolikJKottenbergEPetersJJakobHThielmannM. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res. 2012;110(1):111–115.
14.
HausenloyDJMwamurePKVenugopalV. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007;370(9587):575–579.
15.
IliodromitisEKKyrzopoulosSParaskevaidisIA. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?Heart. 2006;92(12): 1821–1826.
16.
HooleSPHeckPMSharplesL. Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial. Circulation. 2009;119(6):820–827.
17.
BøtkerHEKharbandaRSchmidtMR. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010; 375(9716):727–734.
18.
RentoukasIGiannopoulosGKaoukisA. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2010;3(1):49–55.
19.
LuoSJZhouYJShiDMGeHLWangJLLiuRF. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation. Can J Cardiol. 2013;29(9):1084–1089.
20.
GhaemianANouraeiSMAbdollahianFNaghshvarFGiussaniDANouraeiSA. Remote ischemic preconditioning in percutaneous coronary revascularization: a double-blind randomized controlled clinical trial. Asian Cardiovasc Thorac Ann. 2012;20(5):548–554.
21.
PrasadAGösslMHoytJ. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial. Catheter Cardiovasc Interv. 2013;81(6):930–936.
22.
AhmedRMMohamedEHAshrafM. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention [published online February 13, 2013]. Catheter Cardiovasc Interv. 2013.
23.
BrevoordDKrankePKuijpersMWeberNHollmannMPreckelB. Remote ischemic conditioning to protect against ischemia–reperfusion injury: a systematic review and meta-analysis. PLoS ONE. 2012;7(7):e42179.
24.
YetginTManintveldOCBoersmaE. Remote ischemic conditioning in percutaneous coronary intervention and coronary artery bypass grafting. Circ J. 2012;76(10):2392–2404.
25.
AlrejaGBuganoDLotfiA. Effect of remote ischemic preconditioning on myocardial and renal injury: meta-analysis of randomized controlled trials. J Invasive Cardiol. 2012;24(2):42–48.
26.
BoenglerKSchulzRHeuschG. Loss of cardioprotection with ageing. Cardiovasc Res. 2009;83(2):247–261.
27.
PrzyklenkK. Efficacy of cardioprotective ‘conditioning’ strategies in aging and diabetic cohorts: the co-morbidity conundrum. Drugs Aging. 2011;28(5):331–343.
28.
MurphyESteenbergenC. Gender-based differences in mechanisms of protection in myocardial ischemia–reperfusion injury. Cardiovasc Res. 2007;75(3):478–486.
29.
Mochly-RosenDGrimesKV. Myocardial salvage in acute myocardial infarction—challenges in clinical translation. J Mol Cell Cardiol. 2011;51(4):451–453.
30.
DonatoMBuchholzBRodríguezM. Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischaemic preconditioning. Exp Physiol. 2013;98(2):425–434.
31.
BasalayMBarsukevichVMastitskayaS. Remote ischaemic pre- and delayed postconditioning—similar degree of cardioprotection but distinct mechanisms. Exp Physiol. 2012;97(8):908–917.
32.
MastitskayaSMarinaNGourineA. Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res. 2012;95(4):487–494.
33.
ShimizuMTropakMDiazRJ. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond). 2009;117(5):191–200.
AlbrechtMZittaKBeinB. Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study. Basic Res Cardiol. 2013;108(1):314.
36.
WhittingtonHJHardingIStephensonCI. Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. Cardiovasc Res. 2013;99(4):694–704.
37.
OosterlinckWDresselaersTGeldhofV. Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning. J Thorac Cardiovasc Surg. 2013;145(6):1595–1602.
38.
JensenRVStøttrupNBKristiansenSBBøtkerHE. Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol. 2012;107(5):285.
39.
ErFNiaAMDoppH. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro trial (renal protection trial). Circulation. 2012;126(3):296–303.
40.
ZimmermanJFrommRMeyerD. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation. 1999;99(13):1671–1677.
